Form 8-K - Current report:
SEC Accession No. 0001193125-18-104855
Filing Date
2018-04-02
Accepted
2018-04-02 16:27:02
Documents
2
Period of Report
2018-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d544168d8k.htm 8-K 19034
2 EX-3.1 d544168dex31.htm EX-3.1 11168
  Complete submission text file 0001193125-18-104855.txt   31723
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 18729259
SIC: 3826 Laboratory Analytical Instruments